CORONAVIRUS

The Institut Pasteur mobilization : new projects

The Institut Pasteur in Paris and its International Network of 32 institutes have been extremely active worldwide in responding with science to the pandemic caused by the SARS-CoV-2 coronavirus. Its response currently involves a lot of people at the Institut Pasteur in Paris and several teams in the network in other countries. A coronavirus task force was set up by the Institut Pasteur in January to coordinate COVID-19 research by its teams. Many projects are also being carried out in partnerships or with the support of other organizations. Here are the research projects now under way, several others are set to begin shortly.

All these projects still fall into eight broad research fields:

  • Knowledge of the virus and its pathogenesis

  • Development of research tools

  • Development of diagnostic tests

  • Therapeutic research

  • Vaccine candidates

  • Epidemiological research

  • Modeling

  • Bioinformatics

This week, eight new projects led by the IPIN enrich all of the projects carried out to date:

- CoronaSeroSurv: Serological surveillance of SARS-CoV-2 and seasonal coronaviruses (Paris, Dakar, Cameroon, Ivory Coast)

- AIMDP COVID-19: The use of Artificial Intelligence Methods to Discriminate Covid-19 from other Community Acquired Pneumopathy using Chest X-Ray and CT images (Maroc)

- EPICOVID-19: Household transmission investigation study for SARS in overseas territories (French Guiana, New Caledonia, Guadeloupe)

- COVID-19 risk evaluation: Covid-19 risk evaluation among the household contacts of the first cases in Africa (Dakar, Niger, Cameroon, Madagascar)

- SEN-CoV: Evaluation of clinical presentation and evolution of SARS -CoV-2 coronavirus infection in Senegal (Dakar)

- Healthcare workers Africa: Protocol for assessment of potential risk factors for 2019-novel coronavirus (2019-nCoV) infection among health care workers in a health care setting. (Niger, Dakar, Cameroun, Madagascar)

- POC Project: Developing a rapid diagnostic test to detect SARS-CoV2 virus in various environment (Canada)

- NABCOV:  Identification and isolation of potent human neutralizing antibodies against SARS-CoV-2 (Shanghai, Paris)

See the latest news on these research projects as of May 14, 2020

Print